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Abstract 1 
Background:  Neuroinflammatory signaling may contribute to the pathophysiology of chronic anxiety 2 
disorders. Previous work showed that repeated social defeat (RSD) in mice promoted stress-sensitization 3 
that was characterized by the recurrence of anxiety following sub-threshold stress 24 days after RSD. 4 
Furthermore, splenectomy following RSD prevented the recurrence of anxiety in stress-sensitized (SS) 5 
mice. We hypothesize that the spleen of RSD-exposed mice became a reservoir of primed monocytes that 6 
were released following neuroendocrine activation by sub-threshold stress.  7 
Methods: Mice were subjected to sub-threshold stress (i.e., single cycle of social defeat) 24 days after 8 
RSD, and immune and behavioral parameters were then determined.  9 
Results: Sub-threshold 24 days after RSD re-established anxiety-like behavior that was associated with 10 
egress of Ly6C
hi
 monocytes from the spleen. Moreover, splenectomy prior to RSD blocked monocyte 11 
trafficking to the brain and prevented anxiety-like behavior following sub-threshold stress provided 24 12 
days later. Splenectomy, however, had no effect on monocyte accumulation or anxiety when determined 13 
14 hours after RSD. In addition, splenocytes cultured 24 days after RSD exhibited a primed inflammatory 14 
phenotype. Next, treatment with a peripheral sympathetic inhibitor prior to sub-threshold stress blocked 15 
monocyte redistribution and prevented the re-establishment of anxiety in RSD-sensitized mice.  16 
Conclusion: The spleen served as a unique reservoir of primed monocytes that were readily released 17 
following sympathetic activation by sub-threshold stress that promoted the re-establishment of anxiety. 18 
Collectively, these data show that the spleen is capable of storing primed monocytes that promote 19 
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Introduction 1 
Psychological stress contributes to the development and exacerbation of mental health 2 
disturbances, especially chronic anxiety disorders [1-4]. This is an important phenomenon because 3 
chronic anxiety disorders are the most common psychiatric illness affecting nearly 1 in 3 individuals over 4 
their life span [5, 6]. Despite this, the biological underpinnings of the relationship between psychological 5 
stress and persistent anxiety disorders are not well understood. Recent evidence indicates that 6 
bidirectional communication between the brain and immune system contributes to the etiology of many 7 
psychiatric symptoms and disorders in relation to psychological stress [7-11]. Broadly, chronic 8 
psychosocial stress is associated with a sequela of immunological changes that are often correlated with 9 
poor mental health outcomes. Many of these immunological changes are related to increased 10 
accumulation of primed monocytes that have increased potential for inflammatory signaling [12, 13] that 11 
is resistant to the anti-inflammatory effects of glucocorticoids (GCs) [14, 15]. Moreover, many of the pro-12 
inflammatory effects of stress can be attributed to enhanced monocytopoiesis in the bone marrow that 13 
results in the selective accumulation of the Ly6C
hi
 monocyte subset [13, 16]. Ly6C
hi
 monocytes have a 14 
higher inflammatory capacity compared to their more mature immunoregulatory Ly6C
lo
 counterparts [17, 15 
18]. Additionally, there is evidence that this monocytic immune activation contribute to psychiatric illness 16 
in humans, as reviewed by Beumer et al. [19]. For example, increased perivascular brain-macrophages 17 
were observed in depressed patients who committed suicide [20]. Moreover, PTSD symptoms 18 
significantly correlated with pro-inflammatory NFκB signaling in leukocytes that was related to GC-19 
resistance in monocytes [21, 22]. Thus, these clinical data provide key evidence that links stress, 20 
monocytes, and mood disorders. 21 
Repeated social defeat (RSD) in mice recapitulates key immunological and behavioral deficits [23, 22 
24] associated with psychosocial stress in humans. For example, RSD increased monocytopoiesis in the 23 
bone marrow that caused selective accumulation of Ly6C
hi
 monocytes in circulation, spleen, and brain 24 
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[25, 26]. The accumulation of Ly6C
hi
 monocytes during RSD promoted a pro-inflammatory leukocyte 1 
“transcriptional fingerprint” that was similar to that observed in human populations [13]. Similarly, RSD 2 
promotes a primed monocyte phenotype characterized by enhanced expression of toll-like receptors, co-3 
stimulatory molecules, exaggerated inflammatory response to ex vivo innate immune challenge that is 4 
resistant to inhibition by GCs [27]. Additionally, immune activation and changes in behavior have been 5 
mechanistically linked in this model. For example, the development of prolonged anxiety-like behavior 6 
that is detectable up to 8 days after RSD [28] is dependent upon sympathetic activation of the immune 7 
system [13, 25, 27]. More specific studies revealed that monocyte accumulation in the brain mediated the 8 
relationship between immune activation and prolonged anxiety-like behavior [29]. Taken together, 9 
monocyte trafficking to the brain represent a novel axis of immune-to-brain signaling that promotes 10 
prolonged behavioral responses to stress [30, 31]. 11 
Recent evidence shows that RSD caused long-term sensitization that predisposed mice to have 12 
exaggerated immunological and behavioral responses following subsequent exposure to an acute stressor 13 
[28]. In this study, RSD-exposed mice were termed “stress-sensitized” because they exhibited 14 
exaggerated responses to an otherwise sub-threshold stressor. For instance, exposure to a single cycle of 15 
social defeat 24 days after RSD re-established monocyte trafficking and anxiety-like behavior without 16 
affecting these parameters in naïve, non-stressed controls [28]. Notably, splenectomy in stress-sensitized 17 
mice prevented the re-establishment of monocyte trafficking and anxiety-like behavior 24 days after RSD. 18 
This data was interpreted to indicate that monocyte trafficking from the spleen to the brain promoted the 19 
re-establishment of anxiety in stress-sensitized mice. However, it is currently unclear if the spleen is 20 
unique in its ability to store these releasable monocytes. In immunological studies, other immune organs 21 
were capable of storing myeloid cells, but the spleen was unique in its capacity to functionally contribute 22 
monocytes to distant inflammatory sites [32-35].  23 
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Based on these collective data, the objective of this study was to test the hypothesis that the spleen 1 
of RSD-exposed mice serves as a unique reservoir of primed monocytes that are released following 2 
sympathetic outflow in response to an acute stressor.  Here, we provide several lines of novel evidence 3 
that the spleen is unique in its capacity to maintain and release a population of primed monocytes 24 days 4 
after RSD. Moreover, sub-threshold stress in stress-sensitized (SS) mice caused this pool of primed 5 
monocytes to traffic to the brain and promote the recurrence of anxiety-like behavior.  Furthermore, 6 
inhibition of the peripheral sympathetic nervous system during sub-threshold stress blocked spleen-to-7 
brain monocyte trafficking and prevented the recurrence of anxiety in stress-sensitized mice. These novel 8 
studies reveal that the spleen is capable of maintaining long term neuroimmune sensitization that can 9 
regulate behavioral responses many days after the initial sensitizing event.   10 
 11 
Materials and Methods 12 
Mice. Male C57BL/6 (6–8 weeks old) and CD-1 (retired breeders) mice were purchased from Charles 13 
River Laboratories (Wilmington, MA) and allowed to acclimate to their surroundings for 7–10 d before 14 
initiation of any experimental procedures. C57BL/6 mice were housed in cohorts of three per cage. All 15 
procedures were in accordance with the NIH Guidelines for the Care and Use of Laboratory Animals and 16 
were approved by the Ohio State University Institutional Laboratory Animal Care and Use Committee. 17 
Repeated social defeat (RSD). Mice were subjected to RSD as previously reported [29] and as described 18 
in Supplementary Materials. In brief, an aggressive intruder male CD-1 mouse was introduced into cages 19 
of established male cohorts (three per cage) of C57BL/6 mice for 6 consecutive nights. During each cycle, 20 
submissive behaviors were observed to ensure that the resident mice showed subordinate behavior. At the 21 
end of the 2 h period, the intruder was removed and the residents were left undisturbed until the following 22 
day when the paradigm was repeated. As previously described [28], to study the sensitizing effects of 23 
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RSD, mice were either exposed to control (naïve) or RSD conditions (stress-sensitized). Then, 24 days 1 
later naïve and stress-sensitized (SS) mice were subjected to an additional cycle of social defeat. All 2 
behavior and biological measures were obtained 14 h after the final cycle. 3 
Guanethidine Treatment. Twenty four hours prior to acute social defeat, mice were injected 4 
subcutaneously with either vehicle or 50 mg/kg guanethidine (Santa Cruz Biotechnology, Dallas, TX). 5 
Injection regimen was based on a previous report [36].  6 
Anxiety-like behavior. Anxiety-like behavior was determined using open-field activity as previously 7 
reported [29] and as described in Supplementary Materials.  8 
Isolation of cells from bone marrow, spleen, blood, and brain. Tissues were collected immediately 9 
following CO2 asphyxiation. Cells from BM, spleen, and blood were isolated as previously described [26, 10 
27]. CD11b
+
 brain cells were enriched by Percoll density gradient as previously reported [29]. See 11 
Supplementary Materials for details.  12 
Ex vivo culture with LPS and corticosterone. As previously reported [27, 37], BM and spleen cells were 13 
treated with 1 μg/ml lipopolysaccharide (LPS) from Escherichia coli (serotype 0127:B8, Sigma-Aldrich, 14 
St. Louis, Missouri) and various concentrations of corticosterone (Sigma-Aldrich). Cells were incubated 15 
18 hours for supernatant cytokine measurements or 48 hours for assessment of cell viability. Cell viability 16 
was determined by CellTiter 96 Non-radioactive Proliferation Assay (Promega; Madison, WI), and 17 
supernatant IL-6 was determined by ELISA (BDBiosciences; San Diego, CA). See Supplementary 18 
Materials for details. 19 
Statistical analysis. To determine significant main effects and interactions between main factors, data 20 
were analyzed using two-way ANOVA using the General Linear Model procedures of SAS (Cary, NC). 21 
ANOVA results are presented in figure legends. When there was a main effect of experimental treatment 22 
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or a treatment interaction effect, differences between means were evaluated by an F-protected t-test using 1 
the Least-Significant Difference procedure of SAS. All data are expressed as treatment means ± SEM. 2 
 3 
Results 4 
Recurrence of anxiety-like behavior in stress-sensitized mice was associated with Ly6C
hi
 5 
monocyte egress from the spleen 6 
Previous studies showed that removal of the spleen after RSD prevented both monocyte 7 
trafficking to the brain and the recurrence of anxiety-like behavior in stress-sensitized (SS) mice [28]. To 8 
further examine the possible release of monocytes from the spleen in response to acute stress, the 9 
following experimental design was used. Fig.1A illustrates that mice were stress-sensitized by 6 cycles of 10 
social defeat (SS) or left undisturbed (Naïve). Twenty four days later, mice were exposed to acute social 11 
defeat (acute stress) or left alone as controls. Congruent with our previous findings [28], acute social 12 
defeat promoted the recurrence of anxiety-like behavior that was associated with increased monocyte 13 
trafficking to the brain. For instance, SS mice exposed to acute stress took longer to enter the center 14 
(Fig.1B, p<0.05) and spent less time in the center of the open field (Fig.1C, p<0.05). Additionally, acute 15 
stress increased the accumulation of macrophages in the brain (Fig.1D, p<0.05) and increased mRNA 16 
expression of IL-1β, TNF-α, and CD14 in the brain of SS mice (Fig.1E, all p<0.05). Next, the peripheral 17 
origin of increased brain macrophages was explored. This revealed that acute stress increased the number 18 
of circulating Ly6C
hi
 monocytes in SS mice (Fig.1F, p<0.05) but not in naïve mice. Additionally, the 19 
increase in circulating monocytes was associated with increased release of monocytes from the spleen 20 
(Fig 1G, p<0.05) and bone barrow of SS mice (Fig.1H, p<0.05). Neither stress-sensitization nor acute 21 
stress altered spleen weight (Fig.1I). These results demonstrated that the spleen is indeed a primary source 22 
of monocyte accumulation in SS mice following exposure to acute stress.  23 
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Splenectomy prior to RSD prevented recurrence of monocyte trafficking and anxiety-like behavior 1 
following acute stress in sensitized mice 2 
Previous studies show that removal of the spleen after RSD prevents monocyte accumulation in 3 
the brain following acute stress 24 days later [28]. It is possible, however, that other immune 4 
compartments may compensate for the spleen following splenectomy and function as alternative myeloid 5 
reservoirs [35]. Thus, the next objective was to determine if other immune reservoirs can compensate for 6 
the spleen during stress. To do this, mice were splenectomized 14 days prior to RSD and then exposed to 7 
acute social defeat 24 days later (Fig.2A). This showed that indeed splenectomy prior to RSD prevented 8 
the recurrence of monocyte trafficking and anxiety-like behavior in SS mice. For instance, acute stress in 9 
sham-treated SS increased Ly6C
hi
 monocytes in circulation (Fig.2B-C, p<0.05), increased brain-10 
macrophages (Fig.2D-E, p<0.05), and increased IL-1β, TNF-α, and CD14 mRNA expression in the brain 11 
(Fig.2F, all p<0.1), and all of these effects were prevented by splenectomy (Fig.2B-F). Moreover, 12 
prevention of monocyte trafficking to the brain corresponded with prevention of the recurrence of 13 
anxiety-like behavior. For instance, Sham-SS mice exhibited increased time to enter the center (Fig.2H, 14 
p=0.1) and reduced time spent in the center (Fig.2I, p<0.05) of the open field, while these anxiety-like 15 
behaviors were not detected in splenectomized SS mice (Fig.2H&I). These data are interpreted to indicate 16 
that other immune compartments were unable to compensate for the spleen and act as functional 17 
reservoirs of releasable monocytes following RSD. 18 
Splenectomy did not influence monocyte trafficking or anxiety-like behavior 14 hours after RSD 19 
Our data indicate that monocyte release and anxiety-like behavior following acute stress in SS 20 
mice was dependent on the spleen (Fig.2). It is possible that the spleen was also necessary for some of the 21 
primary immune and behavioral responses to the initial exposure to RSD. To address this, mice were 22 
splenectomized prior to RSD, and behavioral and biological measures were determined 14 hours after the 23 
final cycle (Fig.3A). This showed that the primary immune and behavioral responses to RSD were 24 
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unaltered by splenectomy. Consistent with substantial accumulation of primed myeloid cells in the spleen 1 
[26], RSD increased spleen weight in sham mice (Fig. 3B; p<0.05). Independent of splenectomy, RSD 2 
enhanced myelopoiesis (monocytes and granulocytes) and decreased lymphopoiesis and erythropoiesis in 3 
the bone marrow (Fig.3C-D; all p<0.05). Moreover, splenectomy did not prevent increased Ly6C
hi
 4 
monocytes in circulation following RSD (Fig.3E, p<0.05), did not prevent the accumulation of 5 
macrophages in the brain (Fig.3F-G, p<0.05), and did not prevented increased brain cytokine mRNA 6 
expression of IL-1β, IL-6, TNF-α, CD14, and CCL2 (data not shown) that all occurred independently of 7 
splenectomy. In addition, splenectomy did not prevent the development of anxiety-like behavior 14 hours 8 
after RSD. For instance, RSD increased time to enter the center (Fig.3H, p<0.05) and decreased time 9 
spent in the center (Fig. 3I, p<0.05) of the open field independent of splenectomy. Taken together the 10 
spleen was not required for the primary immune and behavioral response to RSD observed 14 hours after 11 
the last cycle.  12 
RSD increased the accumulation of primed myeloid cell in the spleen that exhibited exaggerated 13 
inflammatory response to ex vivo mitogen challenge   14 
 Data presented here demonstrate that the spleen is necessary for the maintenance of a releasable 15 
pool of monocytes following RSD. Previous reports indicated that RSD increased release and trafficking 16 
of BM-derived monocyte-lineage cells that are both primed and GC-insensitive [26, 37, 38]. For instance, 17 
previous studies showed that RSD caused myeloid cells to produce exaggerated levels of IL-6 in response 18 
to ex vivo LPS stimulation, and this was associated with resistance to the pro-apoptotic effects of GC 19 
stimulation [26, 27]. Additionally, previous results indicated that these primed monocytes seed the spleen 20 
and retain a GC-insensitive phenotype for at least 8 days after RSD [39]. Nonetheless their presence and 21 
phenotype at 24 days after RSD is unknown. To address this, spleen and BM cells were collected from SS 22 
mice and reactivity to LPS and GC sensitivity were assessed ex vivo 24 days after RSD (Fig.4A). IL-6 23 
production following ex vivo LPS stimulation of BM was not different between groups (Fig.4B). 24 
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However, splenocytes from SS mice produced more IL-6 following LPS stimulation compared to cells 1 
from naïve mice (Fig.4C, P<0.05). Additionally, there was increased cell viability in response to LPS 2 
stimulation in splenocytes from SS mice compared to those from naïve mice (Fig. 4D p<0.05). This 3 
exaggerated splenocyte response to LPS stimulation was associated with enhanced baseline mRNA 4 
expression of CD14 (Fig. 4E, p<0.05) but not TLR4 (data not shown).. Next, to determine if this primed 5 
phenotype was associated with GC-insensitivity in SS mice, the effect of increasing corticosterone 6 
concentrations on LPS-induced IL-6 production and cell viability was determined. Fig.4G&F show that 7 
increasing corticosterone concentrations reduced cell viability (Fig.4F, p<0.05) and IL-6 production 8 
(Fig.4G, p<0.05) independent of stress-sensitization. Thus, primed but not GC-insensitive monocytes 9 
were maintained in the spleen for at 24 days after RSD.  10 
Sympathetic inhibition prevented monocyte trafficking and the recurrence of anxiety-like behavior 11 
in SS mice 12 
 Data shown here demonstrate that the spleen is uniquely responsible for the increased availability 13 
of primed and releasable monocytes 24 days after RSD. Despite this, the physiological signaling pathway 14 
that initiates release of monocytes from the spleen in response to acute stress was unknown. Previous 15 
studies demonstrate a role for the SNS in the release of splenic myeloid cells [40]. Therefore, the effect of 16 
guanethidine, a peripheral sympathetic inhibitor, on monocyte release was determined (Fig.5A). 17 
Guanethidine displaces norepinephrine from its vesicles, thus preventing its release in a dose-dependent 18 
manner [41]. This study showed that similar to splenectomy, sympathetic inhibition with guanethidine 19 
prevented monocyte trafficking and anxiety-like behavior in SS mice. For instance, acute stress in 20 
vehicle-treated SS mice increased Ly6C
hi
 monocytes in circulation (Fig.5B&C, p<0.05) and increased 21 
CD45
hi
 brain-macrophages (Fig.5D&E, p<0.05). This redistribution of monocytes was not detected in 22 
guanethidine-treated SS mice (Fig.5B-E). Similarly, acute stress in vehicle-treated SS mice increased 23 
brain mRNA expression of IL-1β and TNF-α (Fig.3F, both p<0.05), and this was also prevented by 24 
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guanethidine treatment.  Moreover, blockade of monocyte trafficking to the brain with guanethidine 1 
corresponded with prevention of anxiety-like behavior in SS mice. For instance, acute stress in vehicle-2 
treated SS mice increased time to enter the center (Fig.5H, p<0.05) and reduced time spent in the center of 3 
the open field (Fig.5I), and these behaviors were not observed in guanethidine treated SS mice 4 
(Fig.5H&I). Taken together, sympathetic inhibition prevented spleen-to-brain monocyte trafficking, and 5 
this corresponded with attenuated anxiety-like behavior and reduced neuroinflammatory signaling 6 
following acute stress exposure. 7 
Discussion 8 
The results presented here demonstrate a novel and critical role for the spleen in the maintenance 9 
of stress-sensitization that persisted for many days after the initial sensitizing, stress event.  First it is 10 
shown that the recurrence of anxiety-like behavior is associated with increased monocyte trafficking from 11 
the spleen and increased macrophage accumulation in the brain. Next, novel data shown here indicate that 12 
the spleen was indispensable for the maintenance of primed and releasable monocytes 24 days after RSD. 13 
For example, splenectomy prior to stress-sensitization blocked monocyte re-distribution and prevented the 14 
recurrence of anxiety in stress-sensitized mice. Notably, no other organ acted as a compensatory reservoir. 15 
Additionally, splenectomy prior to RSD did not attenuate the primary immune and behavioral response to 16 
RSD observed at 14 hours after the final cycle. Thus, the spleen was necessary for the maintenance of 17 
releasable monocytes 24 days after RSD, but was not necessary for the initial production and trafficking 18 
of primed monocytes or anxiety 14 hours after the initial exposure to RSD. The next experiment showed 19 
that splenic monocytes retained a primed but not GC-insensitive phenotype in stress-sensitized mice. This 20 
was interpreted to indicate that RSD primed and mobilized monocyte-lineage cells that persisted in the 21 
spleen for 24 days following cessation of the stressor. Further work addressed physiological signals that 22 
contributed to the release of monocytes from the spleen. These studies showed that pretreatment with the 23 
SNS-inhibitor, guanethidine, prevented monocyte trafficking and anxiety in stress-sensitized mice. Thus, 24 
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sympathetic initiation of spleen-to-brain monocyte trafficking promoted the recurrence of anxiety-like 1 
behavior in sensitized mice.  2 
An important finding in this study was that stress-sensitization following RSD was associated with 3 
an altered myeloid composition of the spleen. First, there was a tendency for increased Ly6C
hi
 monocytes 4 
in the spleen that persisted 24 days after exposure to RSD. Second, accumulation of monocytes in 5 
circulation and brain following acute stress in stress-sensitized mice was associated with a robust 6 
reduction in the number of Ly6C
hi
 monocytes in the spleen. This is consistent with egress of Ly6C
hi
 7 
monocytes from the spleen that accumulated in circulation and brain. This re-distribution of splenic 8 
monocytes characterized here resembles studies of myocardial infarction that revealed that monocyte re-9 
distribution from the spleen contributed to myocardial pathogenesis [32]. Notably, acute stress in stress-10 
sensitized mice also reduced the number of Ly6C
hi
 monocytes in the BM. Nonetheless, our previous work 11 
[28] and data presented here show that cells from the spleen but not the BM are critical for increased 12 
trafficking of primed monocytes in stress-sensitized mice. 13 
The splenectomy studies presented here provide evidence that the spleen is not required for 14 
primary immune and behavioral responses to RSD, but rather, the spleen is necessary for the maintenance 15 
of releasable monocytes 24 days after RSD. This is an important distinction, because it implicates the BM 16 
and not the spleen in the initial production and accumulation of monocytes immediately following RSD. 17 
These results are consistent with other studies of RSD and chronic unpredictable stress that demonstrated 18 
increased production of myeloid cells in the BM [16, 26]. Data from RSD indicated that the monocytes 19 
that accumulate with stress are primed to be more inflammatory in response to challenges (e.g., LPS) and 20 
less sensitive to the anti-inflammatory effects of GCs [27]. Thus, we hypothesize that RSD mobilizes 21 
primed monocytes that seed the spleen and contribute to the maintenance of releasable monocytes with 22 
the ability to traffic in the brain and promote anxiety in stress-sensitized mice. 23 
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Related to the above points, data here support the hypothesis that splenic monocytes from stress-1 
sensitized mice are inherently more reactive to neuroendocrine or immune stimulation. For instance, cells 2 
that persist in the spleen 24 days after RSD appear to have a more primed profile with increased IL-6 3 
secretion following ex vivo LPS stimulation. In contrast, BM cells from stress-sensitized mice were not 4 
more sensitive to LPS stimulation. It is important to mention that these experiments were completed with 5 
whole splenocytes, but we attribute these affects to monocytes. This is supported by previous studies 6 
showing that monocytes/macrophages were the primary cells that responded to LPS stimulation in ex vivo 7 
splenocyte cultures [42]. Although stress-sensitized mice retained a primed monocyte phenotype, they did 8 
not retain the GC-insensitive phenotype that is observed for up to eight days after RSD [27, 39]. We 9 
interpret these data to indicate that the spleen maintains a population of primed monocytes following 10 
stress-sensitization and that these cells can traffic to the brain and promote the recurrence of anxiety 11 
following acute stress many days later. Despite the evidence provided here, it is possible that enhanced 12 
splenic monocyte trafficking observed in stress-sensitized mice is mediated by neuroendocrine 13 
sensitization and was unrelated to immunomodulation. For example, fear conditioning in stress-sensitized 14 
mice might contribute to exaggerated neuroendocrine response to the acute stressor, resulting in sufficient 15 
stimulation to cause the release of splenic monocytes that traffic to the brain and promote anxiety. 16 
Nonetheless, priming of splenic monocytes was observed independent of neuronal mediation. For 17 
instance, splenic myeloid cells demonstrated increased CD14 mRNA expression and enhanced IL-6 18 
production following ex vivo LPS stimulation. Thus persistent splenic priming was observed independent 19 
of neuroendocrine sensitization.  20 
Another important finding was that the release of primed monocytes from the spleen of stress-21 
sensitized mice after acute social defeat was dependent on the SNS. The SNS can interact with the spleen 22 
either through circulating epinephrine or norepinephrine released from the adrenal medulla or through 23 
direct sympathetic innervation [43]. Guanethidine is a peripheral SNS inhibitor that displaces 24 
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norepinephrine from its vesicles and does not affect the CNS [41]. Experiments completed here show that 1 
monocyte release from the spleen was dependent upon SNS activation. For example, guanethidine 2 
blocked accumulation of Ly6C
hi
 monocytes in circulation and blocked macrophage trafficking in the 3 
brain. Notably, this blockade corresponded with prevention of anxiety-like behavior in stress-sensitized 4 
mice. This point is of particular interest because it reveals a clinically relevant pharmacological strategy to 5 
attenuate maladaptive behaviors related to peripheral immunological sensitization. Although 6 
underappreciated, it has been reported that β-adrenergic antagonists (i.e., beta-blockers) have chronic 7 
anxiolytic effects in certain clinical populations [44] that may be related to interactions with the immune 8 
system. Thus, studies here provide a biological mechanism that supports the use of sympathetic inhibitors 9 
to abrogate recurring anxiety promoted by monocyte redistribution.  10 
Overall, the current studies provide evidence that the spleen contributes to long term neuroimmune 11 
sensitization capable of regulating behavioral responses many days after a sensitizing stressful event. For 12 
example, the spleen acted as unique reservoir for primed monocytes following exposure to RSD that were 13 
readily releasable following neuroendocrine activation by acute stress 24 days later. Neuroendocrine 14 
activation by acute stress caused primed monocytes to traffic to the brain and promote the recurrence of 15 
anxiety in sensitized mice. This phenomenon may be relevant because persistent or recurring behavioral 16 
complications observed in several psychiatric populations are associated with immune activation [45]. 17 
Thus, recurring behavioral complications associated with psychological stress may be related to splenic 18 
monocyte re-distribution. Collectively, these findings reveal novel neuroimmune mechanisms that may be 19 
implicated in recurring anxiety disorders.  20 
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Figure Legends: 1 
Figure 1. Acute stress in stress-sensitized (SS) mice caused re-establishment of anxiety-like 2 
behavior that was associated with release monocytes from the spleen A) Male C57BL/6 mice were 3 
stress-sensitized (SS) by 6 repeated cycles of social defeat or left undisturbed as controls (Naïve). Mice 4 
were subjected to acute social defeat 24 days later and anxiety-like behavior and biochemical analyses 5 
were completed 14 h later. Stress-Sensitized mice exposed to acute social defeat exhibited anxiety-like 6 
behavior in the open field with B) increased time to enter the center (interaction, F1,42=4.52, p<0.05) and 7 
C) reduced time spent in the center  (tendency for interaction, F1,44=2.98, p<0.10). D) Acute social defeat 8 
in SS mice increased percentage of macrophages associated with the brain (interaction, F1,21=8.22, 9 
p<0.05) and E) increased Ly6C
hi
 monocytes in circulation (main effect of SS, F1,19=4.47, p≤0.05; 10 
tendency for interaction, F1,19=2.67, p≤0.1). F) Several inflammatory mediators were determined in a 11 
coronal brain section and acute social defeat increased mRNA expression of IL-1β in SS mice 12 
(F1,36=10.55, p<0.01; interaction, F1,36=3.66, p≤0.05), CCL2 (F1,36=5.42, p<0.05), TNF (interaction, 13 
F1,39=4.23, p<0.05), and CD14 (interaction, F1,39=4.46, p<0.05). The relative number of Ly6C
hi
 14 
monocytes was determined in the G) spleen and H) bone marrow. Acute stress reduced the number of  15 
monocytes in both the spleen (interaction, F1,18=8.35, p≤0.01) and bone marrow (interaction, F1,18=9.82, 16 
p≤0.01) of SS mice.  I) Spleen weight was determined and shown as a percentage of body mass. Bars 17 
represent the mean ± SEM. Means with asterisk (*) are significantly different from CON (p<0.05) 18 
according to F-protected post hoc analysis. 19 
Figure 2. Splenectomy prior to stress-sensitization prevented re-establishment of monocyte 20 
trafficking and anxiety-like behavior following subsequent exposure to acute stress. A) Male 21 
C57BL/6 mice were subjected to sham or splenectomy (SPLX) surgery and were allowed to recover for 22 
14 days. Mice were then stress-sensitized (SS) by 6 repeated cycles of social defeat or left undisturbed as 23 
controls (Naïve). Twenty four days later, mice were subjected to acute social defeat, anxiety-like behavior 24 
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and biochemical analyses were completed 14h later. B) Representative flow Bi-variate dot plots of CD115 1 
and Ly6C labeling of blood cells. C) The percentage of Ly6C
hi
 monocytes was determined in blood. 2 
Monocytes in circulation were increased by acute stress in SS mice (F1,25=11.9, p<0.05) and this effect 3 
was blocked by splenectomy (tendency for interaction, F1,25=3.3, p<0.1). D) Representative flow Bi-4 
variate dot plots of CD11b and CD45 labeling on enriched brain macrophages (MΦ) and microglia 5 
(MGL). E) The percentage of brain macrophages was determined and they were increased by acute stress 6 
(F1,25=2.9, p<0.1) and this effect was blocked by splenectomy (tendency for interaction, F1,25=3.52, 7 
p<0.1). F) Several inflammatory mediators were determined in a coronal brain section and acute social 8 
defeat increased mRNA expression of IL-1b (F1,18=2.4, p<0.1), TNFa (F1,18=2.83, p<0.1) and CD14 9 
(F1,18=7.92, p<0.05) in Sham mice but not SPLX mice. G) Spleen weight is shown. Stress-sensitized 10 
Sham mice exhibited anxiety-like behavior in the open field with increased time to enter the center (H; 11 
tendency for main effect of sensitization, F1,25=3.2, p<0.1) and reduced time spent in the center (I; 12 
interaction effect, F1,25=6.5, p<0.05). Bars represent the mean ± SEM.  Means with asterisk (*) are 13 
significantly different from CON (p<0.05) and means with (#) tended to be different from CON (p<0.1), 14 
according to F-protected post hoc analysis. 15 
Figure 3. Splenectomy did not influence myelopoiesis, monocyte redistribution, or the establishment 16 
of anxiety-like behavior following initial exposure to RSD. A) Male C57BL/6 mice were subjected to 17 
sham or splenectomy (SPLX) surgery and were allowed to recover for 14 days. Mice were then exposed 18 
to repeated social defeat (RSD) or left undisturbed as controls (CON), and 14 hrs after the final cycle, 19 
anxiety-like behavior was assessed in the open field. Subsequently, brain, blood, and bone marrow were 20 
collected for analysis. B) RSD increased spleen weight in sham mice (p<0.05). Spleen weights were not 21 
detectable (n.d.) in splenectomized mice. C) Representative flow Bi-variate dot plots of CD31 and Ly6C 22 
labeling on bone marrow cells is shown. D) Independent of splenectomy, RSD decreased erythrocytes 23 
(F1,17=124.5, p<0.0001) and lymphocytes (F1,17=129.2, p<0.01) and increased monocytes (F1,17=120.0, 24 
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p<0.0001) and granulocytes (F1,17=144.9, p<0.0001) in bone marrow. E) RSD increased percent Ly6C
hi
 1 
monocytes in circulation independent of splenoctomy (F1,18=12.0, p<0.01). F) Representative flow Bi-2 
variate dot plots of CD11b and CD45 labeling on enriched brain macrophages (MΦ) and microglia 3 
(MGL). G) RSD increased percent brain macrophages (F1,18=10.4, p<0.01). RSD increased anxiety-like 4 
behavior in the open field with increased time to enter the center (H; F1,23=8.2, p<0. 01) and decreased 5 
time spent in the center (I; F1,23=10.2 p<0. 01). Abbreviations:  Mo, Monocytes; Gr, Granulocytes; Ly, 6 
Lymphocytes; Er, Erythrocytes. Bars represent the mean ± SEM. Means with asterisk (*) are significantly 7 
different from CON (p<0.05) and means with (#) tended to be different from CON (p<0.1), according to 8 
F-protected post hoc analysis.  9 
Figure 4. Stress-sensitization  resulted in the accumulation of primed splenocytes with an enhanced 10 
response to ex vivo mitogen challenge  A) Male C57BL/6 mice were stress-sensitized (SS) by 6 repeated 11 
cycles of social defeat or left undisturbed as controls (Naïve). Twenty four days later, spleen and bone 12 
marrow (BM) cells were cultures ex vivo in the presence of lipopolysaccharide (LPS) and corticosterone 13 
(cort). IL-6 protein was determined in the cell supernatants collected 18 h after LPS in BM and 14 
Splenocytes. B) IL-6 secretion was similar between groups in bone marrow cells. C) The LPS induced IL-15 
6 secretion was higher in splenocytes cultured from SS mice compared to naïve mice (p<0.01). D) Cell 16 
viability of LPS-stimulated splenocytes was increased in SS mice (p<0.05). E) mRNA expression of 17 
CD14 in SS splenocytes was higher than naïve (p<0.01). Next, ex vivo cultures from spleen were 18 
stimulated with LPS for 48 h in the presence of increasing concentrations of corticosterone and cell 19 
viability and IL-6 concentrations were determined. F) There was a main effect of corticosterone on 20 
viability (F5,36=6.84, p<0.0001) and G) on IL-6 production F5,36=4.42, p<0.005) that was independent of 21 
stress. F&G) There was also a main effect of stress on viability (F1,36=9.63, p<0.005) and IL-6 production 22 
(F1,36=4.69, p<0.05). Bars represent the mean ± SEM.  Means with asterisk (*) are significantly different 23 
from CON (p<0.05) according to F-protected post hoc analysis. 24 
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 1 
Figure 5. Guanethidine blocked primed monocyte trafficking from the spleen to the brain and 2 
prevented the re-establishment of anxiety in stress sensitized mice. A) Male C57BL/6 mice were 3 
stress-sensitized (SS) by 6 repeated cycles of social defeat or left undisturbed as controls (Naïve). Mice 4 
were pretreated with guanethidine (Guan) or Vehicle (Veh) prior to acute social defeat. Fourteen hours 5 
after acute social defeat, anxiety-like behavior and biochemical analyses were completed. B) 6 
Representative flow Bi-variate dot plots of CD115 and Ly6C labeling on blood cells. C) The percentage 7 
of Ly6C
hi
 monocytes was determined in blood. Acute stress increased percent Ly6C
hi
 monocytes in SS-8 
Veh mice but not naïve mice (interaction effect, F1,46=4.35, p<0.05).  D) Representative flow Bi-variate 9 
dot plots of CD11b and CD45 labeling on enriched brain macrophages (MΦ) and microglia (MGL). E) 10 
The percentage of brain macrophages was determined and they were increased by acute stress 11 
(F1,46=14.66, p<0.0005) and this effect was blocked by guanethidine (F1,46=7.72, p<0.01). F) Several 12 
inflammatory mediators were determined in a coronal brain section and acute social defeat increased 13 
mRNA expression of IL-1b (F1,22=6.46, p<0.05) and TNFa (F1,22=3.18, p<0.1) in SS-Veh mice but not 14 
SS-Guan mice.G) Spleen weight is shown.  SS vehicle treated mice exhibited anxiety-like behavior in the 15 
open field with increased time to enter the center (H; F1,46=2.42, p≤0.1; main effect of splenectomy; 16 
F1,46=5.66, p<0.05) and reduced time spent in the center (I; tendency for interaction effect, F1,46=2.42, 17 
p≤0.1). Bars represent the mean ± SEM. Bars represent the mean ± SEM.  Means with asterisk (*) are 18 
significantly different from CON (p<0.05) and means with (#) tended to be different from CON (p<0.1), 19 
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